Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - ZymeTx, Inc. (OTC BB:ZMTX.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider
Location
800 Research Parkway, Suite 100
Oklahoma City, OK 73104
Phone: (405) 271-1314
Fax: (405) 271-1944
Email: gibsonc@zymetx.com
Employees (last reported count): 25
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 23%
·Over the last 6 months:
 · 2 insider buys; 1,000  shares
 · one insider sell; 2,000  shares
  (0.1% of insider shares)
·Institutional: 5% (6% of float)
(9 institutions)
·Net Inst. Selling: 5,000  shares (+1.64%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
ZymeTx, Inc. is a biotechnology company engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. ViraZyme, the Company's core technology, exploits the subtle structural differences and characteristics of enzymes to create products used to diagnose and treat viral diseases. The initial viral targets of the Company's diagnostic products are respiratory infections including influenza A and influenza B, respiratory syncytial virus or RSV, parainfluenza and adenovirus. RSV infects humans, usually children, and is an important cause of acute respiratory disease. Adenovirus can cause respiratory disease, keratoconjunctivitis, diarrhea, cystitis and other diseases.
More from Market Guide: Expanded Business Description

Financial Summary
ZMTX is a development stage biotechnology company engaged in the discovery, development and commercialization of unique products for the diagnosis and treatment of viruses. For the nine months ended 3/31/01, revenues decreased 33% to $832 thousand. Net loss increased 2% to $4.1 million. Revenues reflect the effects of a mild influenza season. Net loss also reflects higher R&D expenses due to a decrease in the reimbursement of research expenditures.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
James R. Tolbert III, Chmn.
Norman R. Proulx, Pres./CEO
Fred Hiller, Acting CFO
Craig D. Shimasaki Ph.D., VP.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:ZMTX.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 10-July-2001
$0.25 
Recent Price$0.32 
52-Week High
on 8-Sep-2000
$3.625
Beta0.60 
Daily Volume (3-month avg)27.4K
Daily Volume (10-day avg)11.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-90.2%
52-Week Change
relative to S&P500
-86.8%
Share-Related Items
Market Capitalization$2.20M
Shares Outstanding6.89M
Float5.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.30 
Earnings (ttm)-$1.00 
Earnings (mrq)-$0.20 
Sales (ttm)$0.12 
Cash (mrq)$0.12 
Valuation Ratios
Price/Book (mrq)1.08 
Price/EarningsN/A 
Price/Sales (ttm)2.70 
Income Statements
Sales (ttm)$812.0K
EBITDA (ttm)-$6.45M
Income available to common (ttm)-$6.85M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter31-Mar-2001
Management Effectiveness
Return on Assets (ttm)-100.09%
Return on Equity (ttm)-144.23%
Financial Strength
Current Ratio (mrq)1.25 
Debt/Equity (mrq)0.98 
Total Cash (mrq)$845.0K
Short Interest
As of 8-June-2001
Shares Short33.0K
Percent of Float0.6%
Shares Short
(Prior Month)
2,000 
Short Ratio1.94 
Daily Volume17.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.